It is posited that β-carotene may exert its effects by interacting with three molecules: MMP9, MEIS2, and CTSB, potentially modulating and slowing the progression of CAVD. The gene discussed is MEIS2; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.